Evidence map›Paper›PMID 34453039›Full record

ArticleCell death & disease2021

CXCL12/CXCR4 axis as a key mediator in atrial fibrillation via bioinformatics analysis and functional identification.

Peng Liu, Hongke Sun, Xin Zhou, Qiaozhu Wang, Feng Gao, Yuping Fu, Tong Li, Yixin Wang, Yingqi Li, Boyuan Fan and 4 more

Abstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. [Integrating Bioinformatics and Machine Learning Algorithms to Screen Inflammatory Biomarkers for Atrial Fibrillation and Experimental Validation].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Immune cells and arrhythmias.Cardiovascular research · 2025
    Review
  11. CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy.Medical oncology (Northwood, London, England) · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Peng Liu *Department of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Hongke Sun *Department of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Xin Zhou *Department of Cardiology, The First Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Qiaozhu WangDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Feng GaoSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, China.
Yuping FuDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Tong LiDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Yixin WangDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Yingqi LiDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Boyuan FanDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Xiaoli LiDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China.
Tiannan JiangDepartment of Internal Medicine, Health Care Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Xinghua QinSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, China. xinghuaqin@nwpu.edu.cn.ORCID 0000-0002-0230-6551
Qiangsun ZhengDepartment of Cardiology, The Second Affiliate Hospital of Xi'an Jiaotong University, Xi'an, China. zhengqiangsun@126.com.ORCID 0000-0003-1475-5183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is an increasingly prevalent arrhythmia with significant health and socioeconomic impact. The underlying mechanism of AF is still not well understood. In this study, we sought to identify hub genes involved in AF, and explored their functions and underlying mechanisms based on bioinformatics analysis. Five microarray datasets in GEO were used to identify the differentially expressed genes (DEGs) by Robust Rank Aggregation (RRA), and hub genes were screened out using protein-protein interaction (PPI) network. AF model was established using a mixture of acetylcholine and calcium chloride (Ach-CaCl

Indexed as

Signal TransductionAnimalsAtrial FibrillationBenzylaminesCase-Control StudiesChemokine CXCL12Computational BiologyCyclamsDatabases, GeneticDisease Models, AnimalElectrocardiographyFibrosisGene Expression ProfilingGene OntologyGene Regulatory NetworksHeart AtriaBenzylaminesChemokine CXCL12CXCL12 protein, humanCXCR4 protein, humanCyclamsplerixaforReceptors, CXCR4

Identifiers

PMID34453039
PMCPMC8397768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.